40 Participants Needed

Semantic Feature Analysis Treatment for Aphasia

MM
MS
AA
Overseen ByAlyssa Autenreith, M.A.
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: VA Pittsburgh Healthcare System
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

This randomized controlled comparative effectiveness study examines manipulation of a key component of an established and efficacious treatment for naming impairments in aphasia, along with cognitive and brain correlates of treatment success. Study participants will be randomly assigned to one of two treatment conditions comparing two different versions of Semantic Feature Analysis treatment. Their performance on standardized and study-specific measures will be used to determine which version of the treatment provides superior outcomes, and measures of automatic language processing and functional brain imaging will also be used to identify the underlying neurocognitive mechanisms associated with positive treatment response.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. However, it does require that you do not participate in any other speech-language treatment during the study.

What data supports the effectiveness of the Semantic Feature Analysis Treatment for Aphasia?

Research shows that Semantic Feature Analysis (SFA) treatment helps people with aphasia improve their ability to name objects, both for words they practice and some related words they don't practice. Studies also suggest that the more features patients generate during treatment, the better their naming skills improve, especially for the words they directly work on.12345

Is Semantic Feature Analysis Treatment for Aphasia safe for humans?

The research articles reviewed do not provide specific safety data for Semantic Feature Analysis Treatment for Aphasia, but they focus on its effectiveness in improving naming abilities in individuals with aphasia. There are no reported safety concerns in the studies, suggesting it is generally considered safe for use in humans.12367

What makes Semantic Feature Analysis Treatment unique for aphasia?

Semantic Feature Analysis Treatment is unique because it focuses on improving word retrieval by having patients generate and analyze semantic features (characteristics and meanings) of words, which can enhance naming abilities for both treated and related untreated words. This approach is different from other treatments as it emphasizes patient involvement in generating features and can be modified to include fewer features or combined with other strategies like working memory tasks to improve outcomes.12348

Research Team

WD

William D Hula, Ph.D.

Principal Investigator

VA Pittsburgh Healthcare System

PJ

Patrick J Doyle, Ph.D.

Principal Investigator

VA Pittsburgh Healthcare System

Eligibility Criteria

This trial is for individuals who have aphasia due to a stroke in the left side of their brain, at least 6 months ago. They must be able to manage daily activities on their own or with help from a caregiver, and not have uncontrolled health issues like seizures. Participants should speak English as their first language and not be involved in other speech treatments during the study.

Inclusion Criteria

Sufficient auditory comprehension abilities demonstrated during screening
I am not participating in any other speech therapy during this study.
It's been 6 months since my stroke, which caused speech issues.
See 4 more

Exclusion Criteria

You have a serious mental health condition.
You are currently dependent on drugs or alcohol.
You have a serious problem with speaking or moving.
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Participants receive 60 hours of Semantic Feature Analysis treatment over a five-week period

5 weeks
Daily sessions

Follow-up

Participants are monitored for safety and effectiveness after treatment, including language, eye-tracking, and fMRI testing

8 to 12 weeks post intervention
2 visits (in-person)

Treatment Details

Interventions

  • Semantic Feature Analysis Treatment
Trial Overview The study tests two versions of Semantic Feature Analysis treatment for naming impairments caused by aphasia. It's a randomized controlled trial where participants are assigned randomly to one of the two treatment groups to see which is more effective.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: SFA Experimental InterventionExperimental Treatment1 Intervention
A modified version of Semantic Feature Analysis will be administered.
Group II: SFA Active Comparator InterventionActive Control1 Intervention
A standard version of Semantic Feature Analysis will be administered.

Find a Clinic Near You

Who Is Running the Clinical Trial?

VA Pittsburgh Healthcare System

Lead Sponsor

Trials
36
Recruited
15,900+

Penn State University

Collaborator

Trials
380
Recruited
131,000+

Findings from Research

Semantic Feature Analysis (SFA) has been shown to improve naming abilities in 81.82% of participants with aphasia, based on a review of 21 studies involving 55 individuals.
The studies reviewed demonstrated a small treatment effect, indicating that while SFA is beneficial, further research is needed to better understand its efficacy and how well improvements generalize to everyday communication.
A Systematic Review of Semantic Feature Analysis Therapy Studies for Aphasia.Efstratiadou, EA., Papathanasiou, I., Holland, R., et al.[2019]
A modified semantic feature analysis (SFA) approach using only three features led to improved naming abilities in a 72-year-old individual with both aphasia and apraxia of speech, demonstrating that fewer features can still be effective.
At a 6-week follow-up, the individual maintained improved naming levels compared to pre-treatment, although some decline was observed, suggesting that while the modified SFA can promote long-term improvements, ongoing support may be necessary to sustain these gains.
The use of a modified semantic features analysis approach in aphasia.Hashimoto, N., Frome, A.[2022]
In a study involving 44 participants with chronic aphasia, generating more semantic features during the Semantic Feature Analysis (SFA) treatment improved naming performance for trained words, but not for untrained words, indicating that feature generation is crucial for treatment effectiveness.
Aphasia severity was also found to significantly influence treatment outcomes, suggesting that future research should focus on identifying individuals who may not respond well to therapy and exploring ways to enhance their treatment results.
Effects of Semantic Feature Type, Diversity, and Quantity on Semantic Feature Analysis Treatment Outcomes in Aphasia.Evans, WS., Cavanaugh, R., Gravier, ML., et al.[2021]

References

A Systematic Review of Semantic Feature Analysis Therapy Studies for Aphasia. [2019]
The use of a modified semantic features analysis approach in aphasia. [2022]
Effects of Semantic Feature Type, Diversity, and Quantity on Semantic Feature Analysis Treatment Outcomes in Aphasia. [2021]
Incorporating Metacognitive Strategy Training Into Semantic Treatment Promotes Restitutive and Substitutive Gains in Naming: A Single-Subject Investigation. [2023]
Acquisition and Generalization Responses in Aphasia Naming Treatment: A Meta-Analysis of Semantic Feature Analysis Outcomes. [2020]
Semantic Feature Analysis: Further Examination of Outcomes. [2019]
The role of commonality, distinctiveness and importance of semantic features in persons with aphasia. [2014]
Using a combined working memory - Semantic feature analysis approach to treat anomia in aphasia: A Pilot Study. [2023]